ReP USP - Resultado da busca

Filtros : "Caspi, Rachel R." Removido: "Financiado pelo Biomedical Laboratory Research and Development Service" Limpar

Filtros

Artigo de periodico
IL-4 and IL-10 are both required for the induction of oral 'tolerance POT. 1' (1999)
Rizzo, Luiz Vicente; Morawetz, Renate A.; Miller-Rivero, Nancy E.; Choi, Rosan; Wiggert, Bárbara; Chan, Chi-Chao; Morse III, Herbert C.; Nussenblatt, Robert B.; Caspi, Rachel R.
Fonte: American Association of Immunologists. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZO, Luiz Vicente et al. IL-4 and IL-10 are both required for the induction of oral 'tolerance POT. 1'. American Association of Immunologists, v. 193, p. 2613-2622, 1999Tradução . . Acesso em: 02 nov. 2025.
APA
Rizzo, L. V., Morawetz, R. A., Miller-Rivero, N. E., Choi, R., Wiggert, B., Chan, C. -C., et al. (1999). IL-4 and IL-10 are both required for the induction of oral 'tolerance POT. 1'. American Association of Immunologists, 193, 2613-2622.
NLM
Rizzo LV, Morawetz RA, Miller-Rivero NE, Choi R, Wiggert B, Chan C-C, Morse III HC, Nussenblatt RB, Caspi RR. IL-4 and IL-10 are both required for the induction of oral 'tolerance POT. 1'. American Association of Immunologists. 1999 ; 193 2613-2622.[citado 2025 nov. 02 ]
Vancouver
Rizzo LV, Morawetz RA, Miller-Rivero NE, Choi R, Wiggert B, Chan C-C, Morse III HC, Nussenblatt RB, Caspi RR. IL-4 and IL-10 are both required for the induction of oral 'tolerance POT. 1'. American Association of Immunologists. 1999 ; 193 2613-2622.[citado 2025 nov. 02 ]
Artigo de periodico
Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity (1999)
Xu, Hui; Strassmann, Gideon; Chan, Chi-Chao; Rizzo, Luiz Vicente; Silver, Phyllis B.; Wiggert, Barbara; Caspi, Rachel R.
Fonte: Investigative Ophthalmology and Visual Science. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XU, Hui et al. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science, v. 40, p. 942-950, 1999Tradução . . Acesso em: 02 nov. 2025.
APA
Xu, H., Strassmann, G., Chan, C. -C., Rizzo, L. V., Silver, P. B., Wiggert, B., & Caspi, R. R. (1999). Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science, 40, 942-950.
NLM
Xu H, Strassmann G, Chan C-C, Rizzo LV, Silver PB, Wiggert B, Caspi RR. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science. 1999 ; 40 942-950.[citado 2025 nov. 02 ]
Vancouver
Xu H, Strassmann G, Chan C-C, Rizzo LV, Silver PB, Wiggert B, Caspi RR. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science. 1999 ; 40 942-950.[citado 2025 nov. 02 ]

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2025